CS logo
small CS logo
Fremantle Dermatology

Fremantle, Western Australia, Australia
Skin care clinic in Fremantle, Western Australia
229 High St, Fremantle WA 6160

About Fremantle Dermatology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
9
ASLAN Pharmaceuticals
2
Amgen
2
Bristol-Myers Squibb
2
Dermira, Inc.
2
Galderma R&D
2
Janssen Research & Development, LLC
2
Peplin
2
Arena Pharmaceuticals
1
Botanix Pharmaceuticals
1
CSL Behring
1
Total Rows: 15

Clinical Trials at Fremantle Dermatology


During the past decade, Fremantle Dermatology conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 16 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 11 clinical trials were completed. i.e. 275% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22224466662211111100001133222255Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses
2005-03-01
2005-09-01
Completed
60
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma
2005-03-01
2006-05-01
Completed
60
PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Call Carcinoma
2000-10-01
2002-09-01
Completed
66
Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma
2000-09-01
2006-06-01
Completed
102
Psoriasis Longitudinal Assessment and Registry
2007-06-21
2030-12-31
Recruiting
16,000
Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
2012-10-01
2016-04-04
Completed
250
A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis
2015-05-01
2016-04-01
Completed
212
CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris
2015-04-01
2016-08-01
Completed
124

Rows per page:

1–30 of 30

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Fremantle Dermatology" #1 sponsor was "Eli Lilly and Company" with 9 trials, followed by "ASLAN Pharmaceuticals" with 2 trials sponsored, "Amgen" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Dermira, Inc." with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Fremantle Dermatology" #1 collaborator was "Incyte Corporation" with 4 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Celtaxsys Aus Pty Limited" with 1 trials as a collaborator and "Clinical Network Services (CNS) Pty Ltd" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 9Eli Lilly and Company: 9ASLAN Pharmaceuticals: 2ASLAN Pharmaceuticals: 2Amgen: 2Amgen: 2Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Dermira, Inc.: 2Dermira, Inc.: 2Galderma R&D: 2Galderma R&D: 2Janssen Research &Development, LLC: 2Janssen Research &Development, LLC: 2Peplin: 2Peplin: 2Arena Pharmaceuticals: 1Arena Pharmaceuticals: 1Botanix Pharmaceuticals: 1Botanix Pharmaceuticals: 1

Created with Highcharts 11.1.0Top CollaboratorsIncyte Corporation: 4Incyte Corporation: 4Dermira, Inc.: 2Dermira, Inc.: 2AstraZeneca: 1AstraZeneca: 1Celtaxsys Aus Pty Limited: 1Celtaxsys Aus Pty Limited: 1Clinical NetworkServices (CNS) Pty Ltd:1Clinical NetworkServices (CNS) Pty Ltd:1

Clinical Trials Conditions at Fremantle Dermatology


According to Clinical.Site data, the most researched conditions in "Fremantle Dermatology" are "Atopic Dermatitis" (10 trials), "Psoriasis" (7 trials), "Acne Vulgaris" (4 trials), "Basal Cell Carcinoma" (3 trials) and "Alopecia Areata" (2 trials). Many other conditions were trialed in "Fremantle Dermatology" in a lesser frequency.

Clinical Trials Intervention Types at Fremantle Dermatology


Most popular intervention types in "Fremantle Dermatology" are "Drug" (25 trials), "Biological" (4 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "Baricitinib" (4 trials), "Lebrikizumab" (3 trials), "ASLAN004" (2 trials) and "Apremilast" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Fremantle Dermatology


The vast majority of trials in "Fremantle Dermatology" are 30 trials for "All" genders.

Clinical Trials Status at Fremantle Dermatology


Currently, there are NaN active trials in "Fremantle Dermatology". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Fremantle Dermatology, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Fremantle Dermatology, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 16Phase 3: 16Phase 2: 11Phase 2: 11Phase 1: 2Phase 1: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 20Completed: 20Active, not recruiting: 5Active, not recruiting: 5Terminated: 3Terminated: 3Recruiting: 1Recruiting: 1Withdrawn: 1Withdrawn: 1